A series of novel indole derivatives targeting LsrK as AI-2 quorum sensing (QS) inhibitors against antimicrobial resistance (AMR) were designed, synthesized, and evaluated in vitro and in vivo. 3-Cyano-indol derivative A19 showed more potent activity than that of all reported LsrK inhibitors, with an IC50 value of 340 nM and a KD value of 485 nM. The in-depth biological evaluation indicated that the potent compounds A19, A40, and A49 inhibited biofilm formation and bacterial motility and changed biofilm morphology through AI-2 QS inhibition rather than direct antibacterial effects. Surprisingly, they showed the synergistic eradication effect for preformed biofilms combined with antibiotics and no obvious in vitro hemolysis and cellular toxicity. Moreover, the best-performing compound A40 showed favorable oral PK properties. In summary, this work identified that A40 was a promising lead with a novel scaffold for the further development of LsrK inhibitors as AI-2 QS inhibitors against AMR.
Xing et al. (Wed,) studied this question.